IL141680A0 - Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration - Google Patents

Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Info

Publication number
IL141680A0
IL141680A0 IL14168099A IL14168099A IL141680A0 IL 141680 A0 IL141680 A0 IL 141680A0 IL 14168099 A IL14168099 A IL 14168099A IL 14168099 A IL14168099 A IL 14168099A IL 141680 A0 IL141680 A0 IL 141680A0
Authority
IL
Israel
Prior art keywords
indan
imidazol
ylmethyl
intraspinal
intrathecal
Prior art date
Application number
IL14168099A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL141680A0 publication Critical patent/IL141680A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14168099A 1998-09-28 1999-09-27 Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration IL141680A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10198698P 1998-09-28 1998-09-28
PCT/FI1999/000793 WO2000018400A1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Publications (1)

Publication Number Publication Date
IL141680A0 true IL141680A0 (en) 2002-03-10

Family

ID=22287519

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14168099A IL141680A0 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
IL141680A IL141680A (en) 1998-09-28 2001-02-27 Use of 3 - (H1 - imidazole - 4 - ilmethyl) - indan - 5 - all in the manufacture of a drug for intramuscular, intracranial or epidural administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141680A IL141680A (en) 1998-09-28 2001-02-27 Use of 3 - (H1 - imidazole - 4 - ilmethyl) - indan - 5 - all in the manufacture of a drug for intramuscular, intracranial or epidural administration

Country Status (24)

Country Link
US (1) US6495584B1 (ru)
EP (1) EP1117399B1 (ru)
JP (1) JP4647785B2 (ru)
KR (1) KR100646811B1 (ru)
CN (1) CN1320034A (ru)
AT (1) ATE288753T1 (ru)
AU (1) AU756104B2 (ru)
BG (1) BG105469A (ru)
CA (1) CA2345521C (ru)
CZ (1) CZ299918B6 (ru)
DE (1) DE69923698T2 (ru)
DK (1) DK1117399T3 (ru)
EA (1) EA003216B1 (ru)
EE (1) EE200100193A (ru)
ES (1) ES2237205T3 (ru)
HK (1) HK1039751A1 (ru)
HU (1) HU227634B1 (ru)
IL (2) IL141680A0 (ru)
NO (1) NO330436B1 (ru)
NZ (1) NZ510233A (ru)
PL (1) PL346908A1 (ru)
SK (1) SK3812001A3 (ru)
UA (1) UA61152C2 (ru)
WO (1) WO2000018400A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000192A2 (en) * 1999-06-25 2001-01-04 Orion Corporation Method of administering an imidazole derivative to obtain analgesia
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US5801188A (en) * 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement

Also Published As

Publication number Publication date
CZ2001933A3 (cs) 2001-08-15
HK1039751A1 (zh) 2002-05-10
AU5986099A (en) 2000-04-17
CZ299918B6 (cs) 2008-12-29
JP4647785B2 (ja) 2011-03-09
ES2237205T3 (es) 2005-07-16
NO20011545L (no) 2001-03-26
KR20010079860A (ko) 2001-08-22
NO330436B1 (no) 2011-04-11
PL346908A1 (en) 2002-03-11
CN1320034A (zh) 2001-10-31
NZ510233A (en) 2003-05-30
IL141680A (en) 2007-06-17
EE200100193A (et) 2002-08-15
EP1117399A1 (en) 2001-07-25
SK3812001A3 (en) 2002-02-05
EA200100405A1 (ru) 2001-10-22
DK1117399T3 (da) 2005-03-29
HUP0103864A2 (hu) 2002-05-29
CA2345521C (en) 2009-05-05
ATE288753T1 (de) 2005-02-15
KR100646811B1 (ko) 2006-11-17
EA003216B1 (ru) 2003-02-27
WO2000018400A1 (en) 2000-04-06
DE69923698T2 (de) 2006-01-12
DE69923698D1 (de) 2005-03-17
HU227634B1 (en) 2011-10-28
HUP0103864A3 (en) 2002-08-28
UA61152C2 (en) 2003-11-17
BG105469A (en) 2001-11-30
JP2002525324A (ja) 2002-08-13
AU756104B2 (en) 2003-01-02
NO20011545D0 (no) 2001-03-26
US6495584B1 (en) 2002-12-17
EP1117399B1 (en) 2005-02-09
CA2345521A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
Patel et al. Remifentanil
JPH06157301A (ja) トラマドール物質及び非ステロイド抗炎症薬を含んで成る組成物
JP2006213736A (ja) 鎮痛剤およびその使用
EE200300106A (et) Farmatseutiline kompositsioon kui süsteemne analgeetikum
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
MX2007006637A (es) Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa.
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
WO2003105830A1 (ja) 脳機能を改善する医薬組成物および脳機能を改善するための方法
EP1177791A3 (en) Use of glycogen phosphorylase inhibitors to inhibit tumor growth
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
WO1994016689A1 (en) Analgesic medicinal composition
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
JPS59206309A (ja) 急発作障害の処置及びそれに有用な製薬組成物
IL141680A0 (en) Use of 3-(1h-imidazol--4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
WO2005065372A3 (en) Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
MXPA04010658A (es) Tratamiento de dolor con ifenprodil.
WO2001000192A3 (en) Method of administering an imidazole derivative to obtain analgesia
Bruhn ESRA19-0716 Pain rebound in day surgery: how can we avoid it?
Luthra et al. Intravenous Anesthetic Agents
JP6714225B2 (ja) 肝細胞癌の予防又は治療のための医薬
MXPA02007454A (es) Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor.
US20070043111A1 (en) Use of ifenprodril in the treatment of pain
Rorarius et al. The effect of diclofenac and ketoprofen on halothane MAC in rabbit
JPS646169B2 (ru)

Legal Events

Date Code Title Description
FF Patent granted